KI
RETA

Kula Investments’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Kula Investments’s Portfolio RETA Stock Details RETA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-5,370
Closed -$204K – 905
2022
Q4 		$204K Buy
+5,370
New +$204K 0.06% 516